Protective effect of serum thymic factor, FTS, on cephaloridine-induced nephrotoxicity in rats

Biological and Pharmaceutical Bulletin

Volumn 28, Issue 11, 2005, Pages 2087-2091

  Kohda, Yuka ^a   Matsunaga, Yoshiko ^a   Yonogi, Katsuya ^a   Kawai, Yoshiko ^a   Awaya, Akira ^b   Gemba, Munekazu ^a  

^a OSAKA MEDICAL COLLEGE   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

Cephaloridine; Extracellular signal regulated protein kinase (ERK) activation; Nephrotoxicity; Renal cell injury; Serum thymic factor (FTS)

Indexed keywords

CEFALORIDINE; CREATININE; GLUCOSE; LACTATE DEHYDROGENASE; MITOGEN ACTIVATED PROTEIN KINASE; NITROGEN; THYMULIN; UREA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DAMAGE; CELL LINE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; ELECTRON MICROSCOPY; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; IN VITRO STUDY; IN VIVO STUDY; KIDNEY; KIDNEY CELL; KIDNEY CORTEX; KIDNEY DYSFUNCTION; KIDNEY PROXIMAL TUBULE; MALE; NEPHROTOXICITY; NONHUMAN; PATHOLOGY; RAT; RAT STRAIN; SWINE; UREA NITROGEN BLOOD LEVEL; URINARY EXCRETION;

ANIMALS; BLOTTING, WESTERN; CELL NUCLEUS; CEPHALORIDINE; CEPHALOSPORINS; CREATININE; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENZYME ACTIVATION; KIDNEY; KIDNEY DISEASES; L-LACTATE DEHYDROGENASE; LLC-PK1 CELLS; MALE; MICROSCOPY, ELECTRON; MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PROTEINURIA; RATS; RATS, SPRAGUE-DAWLEY; SWINE; THYMIC FACTOR, CIRCULATING;

EID: 27744502489     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.28.2087     Document Type: Article

References (43)

1. Atkinson R. M., Currie J. P., Davis B., Pratt D. A. H., Sharpe H. M., Tomic E. G., Toxicol. Appl. Pharmacol., 8, 398-406 (1966).
2. Foord R. D., J. Antimicrob. Chemother., 1 (Suppl.), 119-133 (1975).
3. Rush G. F., Heim R. A., Ponsler G. D., Engelhardt J., Toxicol. Pathol., 20, 155-168 (1992).
4. Braza M., J. Infect. Dis., 137, S60-S73 (1978).
5. Jung K. Y., Takeda M., Shimoda M., Narikawa S., Tojo A., Kim D. K., Chairoungdua A., Choi B. K., Kusuhara H., Sugiyama Y., Sekine T., Endou H., Life Sci., 70, 1861-1874 (2002).
6. Tunn B. M., Fernholt M., Schwartz A., J. Pharmacol. Exp. Ther., 191, 311-317 (1974).
7. Wold J. S., Turnipseed S. A., Miller B. L., Toxicol. Appl. Pharmacol., 45, 115-122 (1979).
8. Tune B. M., Minor Electrolyte Metab., 20, 221-231 (1994).
9. Bach J. F., Dardenne M., Pleau J. M., Nature (London), 266, 55-56 (1977).
10. Kaufman D. B., Clin. Exp. Immunol., 39, 722-727 (1980).
11. Bach J. F., Clin. Immunol. Allergy, 3, 133-156 (1983).
12. Bach M. A., Beaurain G., J. Immunol., 122, 1056-1058 (1979).
13. Bach J. F., Dardenne M., Pleau J. M., Bach M. A., Ann. N.Y. Acad. Sci., 249, 186-193 (1975).
14. Dardenne M., Nabama B., Lefancier P., Denien M., Choay J., Bach J. F., Proc. Natl. Acad. Sci. U.S.A., 79, 5370-5373 (1982).
15. Savino W., Dardenne M., Endocr. Rev., 21, 412-443 (2000).
16. Mizutani M., EI-Fotoh M., Mori M., Ono K., Doi K., Awaya A., Matsumoto Y., Onodera T., Arch. Virol., 14, 73-83 (1996).
17. Yamanouchi T., Moromizato H., Kojima S., Shinohara T., Sekino N., Minoda S., Miyashita H., Akaoka I., Eur. J. Pharmacol., 25, 39-46 (1994).
18. Nagai Y., Osanai T., Sakakibara K., Jpn. J. Exp. Med., 52, 213-219 (1982).
19. Barbul A., Shawe T., Frankel H. L., Efron J. E., Wasserkrug H. L., Surgery, 106, 373-377 (1989).
20. Goldstein R. S., Pasino D. A., Hewitt W. R., Hook J. B., Toxicol. Appl. Pharmacol., 83, 261-270 (1986).
21. Rush G., Ponsle G., Toxicol. Appl. Pharmacol., 109, 314-326 (1991).
22. Kuo C. H., Maita K., Sleight S. D., Hook J. B., Toxicol. Appl. Pharmacol., 67, 78-88 (1983).
23. Cojocel C., Hannemann J., Baumann K., Biochim. Biophys. Acta, 834, 402-410 (1985).
24. Xial L., Pimentel D. R., Wang J., Sing K., Colucci W. S., Sawyer D. B., Am. J. Physiol. Cell Physiol., 282, C926-934 (2002).
25. Cobb M. H., Goldsmith E. J., J. Biol. Chem., 270, 14843-14846 (1995).
26. Boulton T. G., Nye S. H., Robbins D. J., Ip N. Y., Radziejewska E., Morgenbesser S. D., Depinho R. A., Paneyotatas N., Cobb M. H., Yancogenbesser G. D., Cell, 65, 663-675 (1991).
27. Davis R. J., J. Biol. Chem., 268, 14553-14556 (1993).
28. Campos-Gonzalez R., Kindy M. S., J. Neurochem., 59, 1955-1958 (1992).
29. Kindy M. S., J. Cereb. Blood Flow Metab., 13, 372-377 (1993).
30. Kohda Y., Gemba M., Jpn. J. Pharmacol., 85, 54-59 (2001).
31. Kohda Y., Gemba M., Biochem. Pharmacol., 64, 543-549 (2002).
32. Zhao X. H., Awaya A., Kobayashi H., Ohnuki T., Tokumitsu Y., Nomura Y., Jpn. J. Pharmacol., 53, 311-319 (1990).
33. Yara S., Kawakami K., Kudeken N., Tohyama K., Teruya K., Chinen T., Awaya A., Saito A., Clin. Exp. Immunol., 124, 77-85 (2001).
34. Kohda Y., Hiramatsu J., Gemba M., Toxicol. Lett., 143, 185-194 (2003).
35. Dignam J. D., Lebovitz R. M., Roeder R. G., Nucleic Acids Res., 11, 1475-1489 (1983).
36. Scheffe H., Biometika, 40, 87-104 (1953).
37. Matsunaga Y., Kawai Y., Kohda Y., Gemba M., J. Toxicol. Sci., 30, 135-144 (2005).
38. Jo S. K., Cho W. Y., Sung S. A., Kim H. K., Won N. H., Kidney Int., 67, 458-466 (2005).
39. Peeters-Joris C., Vandevoorde A. M., Baudhuin P., Biochem. J., 150, 31-39 (1975).
40. Geller B. L., Winge D. R., J. Biol. Chem., 257, 8945-8952 (1982).
41. Kohda Y., Gemba M., J. Pharmacol. Sci., 98, 49-57 (2005).
42. Formisano P., Oriente F., Fiory F., Caruso M., Miele C., Maitan M. A., Andreozzi F., Vigliotta G., Condorelli G., Beguinot F., Mol. Cell. Biol., 20, 6323-6333 (2000).
43. Marais R., Light Y., Mason C., Paterson H., Olson M. F., Marshall C. J., Science, 280, 109-112 (1998).